| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 959-968, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
JM Ward, MR Anver, DC Haines and RE Benveniste
Veterinary and Tumor-Pathology Section, National Cancer Institute, NCI- Frederick Cancer Research, Maryland 21702-1201.
Helicobacter infections cause chronic gastroenteritis in humans and several animal species. We recently discovered a new Helicobacter (H. hepaticus) that is the etiological agent of a unique chronic active hepatitis in mice. Natural infection appeared to be acquired early in life in enzootically infected colonies. Liver lesions arose as focal necrosis and focal nonsuppurative inflammation by 1 to 4 months of age in susceptible mouse strains. By 6 to 8 months, extensive liver involvement included hepatocytomegaly, bile ductular (oval cell) hyperplasia, and cholangitis. There was an age-related increase in proliferating cell nuclear antigen hepatocyte nuclear labeling index. The bacteria were usually found within bile canaliculi as determined by ultrastructural evaluation of liver lesions, the Steiner modification of the Warthin-Starry stain and immunohistochemistry with a rabbit antibody to Helicobacter pylori. Naturally infected mice showed an age- related increase in serum IgG antibodies to Helicobacter hepaticus proteins. The disease was experimentally reproduced by intraperitoneal injection of liver suspensions from affected livers or bacteria cultivated in vitro. The earliest lesions of the experimental disease appeared 4 weeks after injection. The course of spontaneous and experimental infection was slow and insidious and resulted in high titers of antibodies to bacterial proteins. This chronic bacterial infection represents a new model of chronic liver disease.
This article has been cited by other articles:
 |
|
 |
|
  M. D. Stout, G. E. Kissling, F. A. Suarez, D. E. Malarkey, R. A. Herbert, and J. R. Bucher Influence of Helicobacter hepaticus Infection on the Chronic Toxicity and Carcinogenicity of Triethanolamine in B6C3F1 Mice Toxicol Pathol, October 1, 2008; 36(6): 783 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krishnan, A. R. Doster, G. E. Duhamel, and D. F. Becker Characterization of a Helicobacter hepaticus putA Mutant Strain in Host Colonization and Oxidative Stress Infect. Immun., July 1, 2008; 76(7): 3037 - 3044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Garcia, M. M. Ihrig, R. C. Fry, Y. Feng, S. Xu, S. R. Boutin, A. B. Rogers, S. Muthupalani, L. D. Samson, and J. G. Fox Genetic Susceptibility to Chronic Hepatitis Is Inherited Codominantly in Helicobacter hepaticus-Infected AB6F1 and B6AF1 Hybrid Male Mice, and Progression to Hepatocellular Carcinoma Is Linked to Hepatic Expression of Lipogenic Genes and Immune Function-Associated Networks Infect. Immun., May 1, 2008; 76(5): 1866 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E Jergens, J. H Wilson-Welder, A. Dorn, A. Henderson, Z. Liu, R. B Evans, J. Hostetter, and M. J Wannemuehler Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice Gut, July 1, 2007; 56(7): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Alyamani, P. Brandt, J. A. Pena, A. M. Major, J. G. Fox, S. Suerbaum, and J. Versalovic Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases Microbiology, April 1, 2007; 153(4): 1006 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Pratt, K. L. Sachen, H. D. Wood, K. A. Eaton, and V. B. Young Modulation of Host Immune Responses by the Cytolethal Distending Toxin of Helicobacter hepaticus. Infect. Immun., August 1, 2006; 74(8): 4496 - 4504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Kusters, A. H. M. van Vliet, and E. J. Kuipers Pathogenesis of Helicobacter pylori Infection Clin. Microbiol. Rev., July 1, 2006; 19(3): 449 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ceelen, A. Decostere, G. Verschraegen, R. Ducatelle, and F. Haesebrouck Prevalence of Helicobacter pullorum among Patients with Gastrointestinal Disease and Clinically Healthy Persons J. Clin. Microbiol., June 1, 2005; 43(6): 2984 - 2986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Rogers, S. R. Boutin, M. T. Whary, N. Sundina, Zhongming Ge, K. Cormier, and J. G. Fox Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice Toxicol Pathol, October 1, 2004; 32(6): 668 - 677. [Abstract] [PDF]
|
|
|
|
|
|
P. Avenaud, B. Le Bail, K. Mayo, A. Marais, R. Fawaz, P. Bioulac-Sage, and F. Megraud Natural History of Helicobacter hepaticus Infection in Conventional A/J Mice, with Special Reference to Liver Involvement Infect. Immun., June 1, 2003; 71(6): 3667 - 3672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Feng, E. Hodzic, L. V. Kendall, A. Smith, K. Freet, and S. W. Barthold Cloning and Expression of a Helicobacter bilis Immunoreactive Protein Clin. Vaccine Immunol., May 1, 2002; 9(3): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garcia, S. E. Erdman, S. Xu, Y. Feng, A. B. Rogers, M. D. Schrenzel, J. C. Murphy, and J. G. Fox Hepatobiliary Inflammation, Neoplasia, and Argyrophilic Bacteria in a Ferret Colony Vet. Pathol., March 1, 2002; 39(2): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Franklin, P. L. Gorelick, L. K. Riley, F. E. Dewhirst, R. S. Livingston, J. M. Ward, C. S. Beckwith, and J. G. Fox Helicobacter typhlonius sp. nov., a Novel Murine Urease-Negative Helicobacter Species J. Clin. Microbiol., November 1, 2001; 39(11): 3920 - 3926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. K. Choi, J. H. Han, and H. S. Joo Identification of Novel Helicobacter Species in Pig Stomachs by PCR and Partial Sequencing J. Clin. Microbiol., September 1, 2001; 39(9): 3311 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Burich, R. Hershberg, K. Waggie, W. Zeng, T. Brabb, G. Westrich, J. L. Viney, and L. Maggio-Price Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G764 - G778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Singh, C. Leuratti, S. Josyula, M. A. Sipowicz, B. A. Diwan, K. S. Kasprzak, H. A. J. Schut, L. J. Marnett, L. M. Anderson, and D. E. G. Shuker Lobe-specific increases in malondialdehyde DNA adduct formation in the livers of mice following infection with Helicobacter hepaticus Carcinogenesis, August 1, 2001; 22(8): 1281 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Shomer, C. A. Dangler, M. D. Schrenzel, M. T. Whary, S. Xu, Y. Feng, B. J. Paster, F. E. Dewhirst, and J. G. Fox Cholangiohepatitis and Inflammatory Bowel Disease Induced by a Novel Urease-Negative Helicobacter Species in A/J and Tac:ICR:Hascidf RF Mice Experimental Biology and Medicine, May 1, 2001; 226(5): 420 - 428. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Fox, L. Handt, B. J. Sheppard, S. Xu, F. E. Dewhirst, S. Motzel, and H. Klein Isolation of Helicobacter cinaedi from the Colon, Liver, and Mesenteric Lymph Node of a Rhesus Monkey with Chronic Colitis and Hepatitis J. Clin. Microbiol., April 1, 2001; 39(4): 1580 - 1585. [Abstract] [Full Text]
|
|
|
|
|
|
J. V. Solnick and D. B. Schauer Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases Clin. Microbiol. Rev., January 1, 2001; 14(1): 59 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brayton, M. Justice, and C. A. Montgomery Evaluating Mutant Mice: Anatomic Pathology Vet. Pathol., January 1, 2001; 38(1): 1 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Diwan, G. Ramakrishna, L. M. Anderson, and D. Ramljak Overexpression of Grb2 in Inflammatory Lesions and Preneoplastic Foci and Tumors Induced by N-Nitrosodimethylamine in Helicobacter hepaticus--Infected and -Noninfected A/J Mice Toxicol Pathol, July 1, 2000; 28(4): 548 - 554. [Abstract] [PDF]
|
|
|
|
|
|
H.-O. Nilsson, J. Taneera, M. Castedal, E. Glatz, R. Olsson, and T. Wadström Identification of Helicobacter pylori and Other Helicobacter Species by PCR, Hybridization, and Partial DNA Sequencing in Human Liver Samples from Patients with Primary Sclerosing Cholangitis or Primary Biliary Cirrhosis J. Clin. Microbiol., March 1, 2000; 38(3): 1072 - 1076. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Livingston, L. K. Riley, R. R. Hook Jr., C. L. Besch-Williford, and C. L. Franklin Cloning and Expression of an Immunogenic Membrane-Associated Protein of Helicobacter hepaticus for Use in an Enzyme-Linked Immunosorbent Assay Clin. Vaccine Immunol., September 1, 1999; 6(5): 745 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ihrig, M. D. Schrenzel, and J. G. Fox Differential Susceptibility to Hepatic Inflammation and Proliferation in AXB Recombinant Inbred Mice Chronically Infected with Helicobacter hepaticus Am. J. Pathol., August 1, 1999; 155(2): 571 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Kullberg, J. M. Ward, P. L. Gorelick, P. Caspar, S. Hieny, A. Cheever, D. Jankovic, and A. Sher Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism Infect. Immun., November 1, 1998; 66(11): 5157 - 5166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, J. G. Fox, M. T. Whary, L. Yan, B. Shames, and Z. Zhao SCID/NCr Mice Naturally Infected with Helicobacter hepaticus Develop Progressive Hepatitis, Proliferative Typhlitis, and Colitis Infect. Immun., November 1, 1998; 66(11): 5477 - 5484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Hailey, J. K. Haseman, J. R. Bucher, E. Radovsky, D. E. Malarkey, R. T. Miller, A. Nyska, and R. R. Maronpot Impact of Helicobacter hepaticus Infection in B6C3F1 Mice from Twelve National Toxicology Program Two-Year Carcinogenesis Studies Toxicol Pathol, September 1, 1998; 26(5): 602 - 611. [Abstract] [PDF]
|
|
|
|
|
|
J. G. Fox, J. A. MacGregor, Z. Shen, X. Li, R. Lewis, and C. A. Dangler Comparison of Methods of Identifying Helicobacter hepaticus in B6C3F1 Mice Used in a Carcinogenesis Bioassay J. Clin. Microbiol., May 1, 1998; 36(5): 1382 - 1387. [Abstract] [Full Text]
|
|
|
|
|
|
J. K. Haseman, J. R. Hailey, and R. W. Morris Spontaneous Neoplasm Incidences in Fischer 344 Rats and B6C3F1 Mice in Two-Year Carcinogenicity Studies: A National Toxicology Program Update Toxicol Pathol, May 1, 1998; 26(3): 428 - 441. [Abstract] [PDF]
|
|
|
|
|
|
A. Nyska, R. R. Maronpot, S. R. Eldridge, J. K. Haseman, and J. R. Hailey Alteration in Cell Kinetics in Control B6C3F1 Mice Infected with Helicobacter hepaticus Toxicol Pathol, November 1, 1997; 25(6): 591 - 596. [Abstract] [PDF]
|
|
|
|
|
|
B. A. Diwan, J. M. Ward, D. Ramljak, and L. M. Anderson Promotion by Helicobacter hepaticus-Induced Hepatitis of Hepatic Tumors Initiated by N-Nitrosodimethylamine in Male A/JCr Mice Toxicol Pathol, November 1, 1997; 25(6): 597 - 605. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Ward, M.-A. Shibata, and D. E. Devor Emerging Issues in Mouse Liver Carcinogenesis Toxicol Pathol, January 1, 1996; 24(1): 129 - 137. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
